title: Gabapentin neurotoxicity in a chronic haemodialysis patient.
authors.forename: N
authors.initials: N
authors.lastname: Bassilios
authors.forename: V
authors.initials: V
authors.lastname: Launay-Vacher
authors.forename: N
authors.initials: N
authors.lastname: Khoury
authors.forename: E
authors.initials: E
authors.lastname: Rondeau
authors.forename: G
authors.initials: G
authors.lastname: Deray
authors.forename: J D
authors.initials: JD
authors.lastname: Sraer
mesh_terms: D000085:Acetates / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D000328:Adult; D000588:Amines; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D003509:Cyclohexanecarboxylic Acids; D004827:Epilepsy / Q000097:blood / Q000150:complications / Q000188:drug therapy; D004832:Epilepsy, Absence / Q000209:etiology; D005260:Female; D000077206:Gabapentin; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000628:therapy; D009420:Nervous System / Q000187:drug effects*; D006435:Renal Dialysis / Q000009:adverse effects*; D005680:gamma-Aminobutyric Acid
chemical_list: D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin